# Otsuka Pharmaceutical Development & Commercialization, Inc - Inspection Records

Source: https://www.keypedia.com/companies/otsuka-pharmaceutical-development-commercialization-inc/03896536-2cca-444e-b073-5c54859f3e6f

> Inspection records and compliance data for Otsuka Pharmaceutical Development & Commercialization, Inc in Rockville, Maryland. Access full analysis and detailed observations.

---

## Details

- Name: Otsuka Pharmaceutical Development & Commercialization, Inc
- FEI Number: 3000718406
- City: Rockville
- State: Maryland
- Country Name: United States
- Address Line 1: 2440 Research Blvd
- Zip Code: 20850

## Related Documents

- [FDA Inspection 1273580 - Otsuka Pharmaceutical Development & Commercialization, Inc - 2025-07-18](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/7e188bd7-5b20-4f3a-a030-2c12ba9f5268) — source: FDA, date: July 18, 2025
- [FDA Inspection 1273580 - Otsuka Pharmaceutical Development & Commercialization, Inc - 2025-07-18](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/762d8a44-5e9e-43a3-ae9c-84774676ec0a) — classification: No Action Indicated (NAI), source: FDA, date: July 18, 2025
- [FDA Inspection 1219094 - Otsuka Pharmaceutical Development & Commercialization, Inc - 2023-09-07](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/1b412766-329c-464a-9391-c8d96d395d36) — classification: No Action Indicated (NAI), source: FDA, date: September 7, 2023
- [FDA Inspection 1199647 - Otsuka Pharmaceutical Development & Commercialization, Inc - 2023-02-27](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/c0b73b40-3560-428f-bc64-42f12e4f294e) — classification: No Action Indicated (NAI), source: FDA, date: February 27, 2023
- [FDA Inspection 1074034 - Otsuka Pharmaceutical Development & Commercialization, Inc - 2018-11-14](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/62885d55-25d4-40e7-ac5c-65cf30ca42d1) — classification: No Action Indicated (NAI), source: FDA, date: November 14, 2018
- [483 - Otsuka Pharmaceutical Development & Commercialization, Inc - 2017-05-19](https://www.keypedia.com/records/483/otsuka-pharmaceutical-development-commercialization-inc/39edbca6-da40-46e2-9927-8ecfdc44b721) — source: FDA, date: May 19, 2017
- [FDA Inspection 1012315 - Otsuka Pharmaceutical Development & Commercialization, Inc - 2017-05-19](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/1e46099a-b4ca-4c96-bfe5-74682079173f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 19, 2017
- [FDA Inspection 1012315 - Otsuka Pharmaceutical Development & Commercialization, Inc - 2017-05-19](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/f3bcf6ce-df75-4dc0-9a49-f42fdb864c10) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 19, 2017
- [FDA Inspection 925330 - Otsuka Pharmaceutical Development & Commercialization, Inc - 2015-05-06](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/bafd003e-4fb5-4cb0-983b-2c0d7ef8c065) — classification: No Action Indicated (NAI), source: FDA, date: May 6, 2015
- [FDA Inspection 925330 - Otsuka Pharmaceutical Development & Commercialization, Inc - 2015-05-06](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/6f8fc2f3-3b7b-41f0-8463-cce58b7ce62f) — classification: No Action Indicated (NAI), source: FDA, date: May 6, 2015
- [FDA Inspection 904240 - Otsuka Pharmaceutical Development & Commercialization, Inc - 2014-11-19](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/8595cd0f-9809-44c7-be7e-74bff3c941e8) — classification: No Action Indicated (NAI), source: FDA, date: November 19, 2014

## Related Companies

- [LSG Sky Chefs, Inc.](https://www.keypedia.com/companies/lsg-sky-chefs-inc/3085f68f-1f76-4533-aa9d-7cf41df31c24)
- [Hans Bakery,  Inc. dba Andersen's Bakery](https://www.keypedia.com/companies/hans-bakery-inc-dba-andersens-bakery/fbde2ec4-6d23-4b6b-ad78-51ce92e16a29)
- [Dole Fresh Vegetables, Inc.](https://www.keypedia.com/companies/dole-fresh-vegetables-inc/7c8aae36-43f2-4551-a051-16632955fcc3)
- [OneBlood, Inc.](https://www.keypedia.com/companies/oneblood-inc/79fab388-8638-45e8-9ea6-ca699ba36a75)
- [Meta Labs Pharmaceuticals LLC](https://www.keypedia.com/companies/meta-labs-pharmaceuticals-llc/07e34339-7add-45ad-a256-eed50491a635)
- [Geisinger Medical Center Blood Bank](https://www.keypedia.com/companies/geisinger-medical-center-blood-bank/9f4506a2-4fe0-4222-a726-a699e9c7e943)
- [Prolacta Bioscience Inc](https://www.keypedia.com/companies/prolacta-bioscience-inc/fafc52a9-8c2a-4c2a-9889-e42779d7c654)
- [Emory University Hospital Midtown- Center for Transfusion & Cellular Therapies](https://www.keypedia.com/companies/emory-university-hospital-midtown-center-for-transfusion-cellular-therapies/06bf6f2c-3d85-4814-bfe7-6e1d8b2813c5)
- [Lipari Foods Operating Company, LLC.](https://www.keypedia.com/companies/lipari-foods-operating-company-llc/88d727cb-12fe-4d23-bf82-af4c799a6604)
- [Bio-Botanica, Inc.](https://www.keypedia.com/companies/bio-botanica-inc/fe1e9e8d-acab-4b7d-81df-7ad795b2570a)

## Related Officers

- [investigator](https://www.keypedia.com/people/james-m-simpson/3c0113ae-d846-4e37-aafa-13d58c465fa3)